Cardiac resynchronisation therapy (CRT) has become the cornerstone of heart failure (HF) treatment. Despite the obvious benefit from this therapy, an estimated 30% of CRT patients do not respond ("non-responders"). The cause of "non-response" is multi-factorial and includes suboptimal device settings. To optimise CRT settings, echocardiography has been considered the gold standard but has limitations: it is user dependent and consumes time and resources. CRT proprietary algorithms have been developed to perform device optimisation efficiently and with limited resources. In this review, we discuss CRT optimisation including the various adopted proprietary algorithms and conduction system pacing
This editorial refers to 'Contractility sensor-guided optimization of cardiac resynchronization ther...
Cardiac resynchronization therapy (CRT) is an established therapy for patients with heart failure an...
Cardiac resynchronization therapy (CRT) is now a recommended treatment in patients with severe heart...
Cardiac resynchronisation therapy (CRT) has become the cornerstone of heart failure (HF) treatment. ...
Cardiac resynchronization therapy (CRT) improves symptoms and cardiac function, reduces hospitalizat...
Cardiac resynchronization therapy (CRT) is an established nonpharmacological treatment for patients ...
Cardiac resynchronization therapy (CRT) has been shown to improve clinical outcomes in patients with...
Background: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in patients suff...
Cardiac resynchronization therapy (CRT) is a well-established treatment for symptomatic heart failur...
Cardiac Resynchronisation Therapy (CRT) is now an established therapeutic option for patients with s...
Heart failure carries a very poor prognosis, unless treated with the appropriate pharmacological age...
More than twenty years of research has established the role of cardiac resynchronization therapy (CR...
Aims: This study sought to describe and evaluate the impact of a routine in‐hospital cardiac resynch...
Since the first report on biventricular pacing in 1994, cardiac resynchronization therapy (CRT) has ...
Heart failure continues to be a major public health problem with high morbidity and mortality rates,...
This editorial refers to 'Contractility sensor-guided optimization of cardiac resynchronization ther...
Cardiac resynchronization therapy (CRT) is an established therapy for patients with heart failure an...
Cardiac resynchronization therapy (CRT) is now a recommended treatment in patients with severe heart...
Cardiac resynchronisation therapy (CRT) has become the cornerstone of heart failure (HF) treatment. ...
Cardiac resynchronization therapy (CRT) improves symptoms and cardiac function, reduces hospitalizat...
Cardiac resynchronization therapy (CRT) is an established nonpharmacological treatment for patients ...
Cardiac resynchronization therapy (CRT) has been shown to improve clinical outcomes in patients with...
Background: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in patients suff...
Cardiac resynchronization therapy (CRT) is a well-established treatment for symptomatic heart failur...
Cardiac Resynchronisation Therapy (CRT) is now an established therapeutic option for patients with s...
Heart failure carries a very poor prognosis, unless treated with the appropriate pharmacological age...
More than twenty years of research has established the role of cardiac resynchronization therapy (CR...
Aims: This study sought to describe and evaluate the impact of a routine in‐hospital cardiac resynch...
Since the first report on biventricular pacing in 1994, cardiac resynchronization therapy (CRT) has ...
Heart failure continues to be a major public health problem with high morbidity and mortality rates,...
This editorial refers to 'Contractility sensor-guided optimization of cardiac resynchronization ther...
Cardiac resynchronization therapy (CRT) is an established therapy for patients with heart failure an...
Cardiac resynchronization therapy (CRT) is now a recommended treatment in patients with severe heart...